Planet Labs PBC (PL) 10-Q14 Dec 222023 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Oct. 31, 2022	Dec. 09, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-40166
Entity Registrant Name	Planet Labs PBC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-4299396
Entity Address, Address Line One	645 Harrison Street
Entity Address, Address Line Two	Floor 4
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	829-3313
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001836833
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--01-31
Common Class A
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	PL
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		250,946,458
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		21,157,586
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase Class A common stock, at an exercise price of $11.50 per share
Trading Symbol	PL WS
Security Exchange Name	NYSE

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Statement [Abstract]
Revenue	[1]	$ 49,704	$ 31,700	$ 138,281	$ 94,063
Cost of revenue	[1]	24,728	20,811	73,333	59,757
Gross profit		24,976	10,889	64,948	34,306
Operating expenses
Research and development	[1]	27,598	14,959	79,085	39,521
Sales and marketing		19,383	12,441	57,721	33,691
General and administrative		20,627	11,800	61,128	31,939
Total operating expenses		67,608	39,200	197,934	105,151
Loss from operations		(42,632)	(28,311)	(132,986)	(70,845)
Interest income		2,853	8	4,276	12
Interest expense		0	(2,612)	0	(7,750)
Change in fair value of convertible notes and warrant liabilities		(19)	(10,172)	5,369	(11,429)
Other income (expense), net		1	(60)	123	(325)
Total other income (expense), net		2,835	(12,836)	9,768	(19,492)
Loss before provision for income taxes		(39,797)	(41,147)	(123,218)	(90,337)
Provision for income taxes		439	394	907	822
Net loss		$ (40,236)	$ (41,541)	$ (124,125)	$ (91,159)
Basic net loss per share attributable to common stockholders (in dollars per share)		$ (0.15)	$ (0.88)	$ (0.47)	$ (1.97)
Diluted net loss per share attributable to common stockholders (in dollars per share)		$ (0.15)	$ (0.88)	$ (0.47)	$ (1.97)
Basic weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares)		267,947,661	47,137,377	266,104,962	46,360,220
Diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares)		267,947,661	47,137,377	266,104,962	46,360,220

[1]Balance includes related-party transactions entered into with Google. See Note 12.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)		Oct. 31, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents		$ 199,124,000	$ 490,762,000
Short-term investments		226,163,000	0
Accounts receivable, net of allowance of $1,488 and $1,031, respectively		29,009,000	44,373,000
Prepaid expenses and other current assets		26,347,000	16,385,000
Total current assets		480,643,000	551,520,000
Property and equipment, net		115,385,000	133,280,000
Capitalized internal-use software, net		11,181,000	10,768,000
Goodwill		103,219,000	103,219,000
Intangible assets, net		12,419,000	14,197,000
Restricted cash, non-current		5,163,000	5,743,000
Operating lease right-of-use assets		15,806,000	0
Other non-current assets		3,412,000	2,714,000
Total assets		747,228,000	821,441,000
Current liabilities
Accounts payable		2,557,000	2,850,000
Accrued and other current liabilities	[1]	42,629,000	48,823,000
Deferred revenue	[1]	47,698,000	64,233,000
Liability from early exercise of stock options		13,446,000	16,135,000
Operating lease liabilities, current		3,538,000	0
Total current liabilities		109,868,000	132,041,000
Deferred revenue	[1]	0	3,579,000
Deferred hosting costs	[1]	9,853,000	12,149,000
Public and private placement warrant liabilities		17,855,000	23,224,000
Deferred rent		0	798,000
Operating lease liabilities, non-current		14,024,000	0
Other non-current liabilities		1,461,000	1,405,000
Total liabilities		153,061,000	173,196,000
Commitments and contingencies (Note 9)
Stockholders’ equity
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at October 31, 2022 and January 31, 2022, 248,215,356 and 241,017,687 Class A shares issued and outstanding at October 31, 2022 and January 31, 2022, respectively, 21,157,586 Class B shares issued and outstanding at October 31, 2022 and January 31, 2022, 0 Class C shares issued and outstanding at October 31, 2022 and January 31, 2022	[1]	27,000	27,000
Additional paid-in capital		1,494,652,000	1,423,151,000
Accumulated other comprehensive income		943,000	2,096,000
Accumulated deficit		(901,455,000)	(777,029,000)
Total stockholders’ equity		594,167,000	648,245,000
Total liabilities and stockholders’ equity		$ 747,228,000	$ 821,441,000

[1]Balance includes related-party transactions entered into with Google, LLC (“Google”). See Note 12.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Accounts receivable, allowance	$ 1,488	$ 1,031
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common Class A
Common stock, shares authorized (in shares)	570,000,000	570,000,000
Common stock, shares issued (in shares)	248,215,356	241,017,687
Common stock, shares outstanding (in shares)	248,215,356	241,017,687
Common Class B
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	21,157,586	21,157,586
Common stock, shares outstanding (in shares)	21,157,586	21,157,586
Common Class C
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (40,236)	$ (41,541)	$ (124,125)	$ (91,159)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(235)	139	82	335
Change in fair value of available-for-sale securities	(1,538)	0	(1,235)	0
Other comprehensive income (loss), net of tax	(1,773)	139	(1,153)	335
Comprehensive loss	$ (42,009)	$ (41,402)	$ (125,278)	$ (90,824)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2021			131,252,627	43,946,198
Beginning balance at Jan. 31, 2021	$ 107,511		$ 13	$ 4	$ 745,630	$ 1,769	$ (639,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				637,684
Issuance of Class A common stock from the exercise of common stock options	2,156				2,156
Stock-based compensation	3,243				3,243
Change in translation	274					274
Net loss	(29,255)						(29,255)
Ending balance (in shares) at Apr. 30, 2021			131,252,627	44,583,882
Ending balance at Apr. 30, 2021	83,929		$ 13	$ 4	751,029	2,043	(669,160)
Beginning balance (in shares) at Jan. 31, 2021			131,252,627	43,946,198
Beginning balance at Jan. 31, 2021	107,511		$ 13	$ 4	745,630	1,769	(639,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net unrealized gain on available-for-sale securities, net of taxes	0
Net loss	(91,159)
Ending balance (in shares) at Oct. 31, 2021			131,252,627	48,157,747
Ending balance at Oct. 31, 2021	37,193		$ 13	$ 4	766,136	2,104	(731,064)
Beginning balance (in shares) at Jan. 31, 2021			131,252,627	43,946,198
Beginning balance at Jan. 31, 2021	$ 107,511		$ 13	$ 4	745,630	1,769	(639,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Ending balance (in shares) at Jan. 31, 2022				262,175,273
Ending balance at Jan. 31, 2022	$ 648,245	$ (301)		$ 27	1,423,151	2,096	(777,029)	$ (301)
Beginning balance (in shares) at Apr. 30, 2021			131,252,627	44,583,882
Beginning balance at Apr. 30, 2021	83,929		$ 13	$ 4	751,029	2,043	(669,160)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				2,358,627
Issuance of Class A common stock from the exercise of common stock options	1,724				1,724
Stock-based compensation	5,066				5,066
Change in translation	(78)					(78)
Net loss	(20,363)						(20,363)
Ending balance (in shares) at Jul. 31, 2021			131,252,627	46,942,509
Ending balance at Jul. 31, 2021	70,278		$ 13	$ 4	757,819	1,965	(689,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				1,215,238
Issuance of Class A common stock from the exercise of common stock options	2,986				2,986
Vesting of restricted stock awards	896				896
Issuance of recourse note to employee	(389)				(389)
Stock-based compensation	4,824				4,824
Net unrealized gain on available-for-sale securities, net of taxes	0
Change in translation	139					139
Net loss	(41,541)						(41,541)
Ending balance (in shares) at Oct. 31, 2021			131,252,627	48,157,747
Ending balance at Oct. 31, 2021	37,193		$ 13	$ 4	766,136	2,104	(731,064)
Beginning balance (in shares) at Jan. 31, 2022				262,175,273
Beginning balance at Jan. 31, 2022	648,245	(301)		$ 27	1,423,151	2,096	(777,029)	(301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				3,524,182
Issuance of Class A common stock from the exercise of common stock options	6,203				6,203
Issuance of Class A common stock upon vesting of restricted stock units (in shares)				215,178
Vesting of early exercised stock options (in shares)				91,911
Vesting of early exercised stock options	896				896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)				(75,442)
Class A common stock withheld to satisfy employee tax withholding obligations	(411)				(411)
Stock-based compensation	20,259				20,259
Change in translation	175					175
Net loss	(44,360)						(44,360)
Ending balance (in shares) at Apr. 30, 2022				265,931,102
Ending balance at Apr. 30, 2022	630,706			$ 27	1,450,098	2,271	(821,690)
Beginning balance (in shares) at Jan. 31, 2022				262,175,273
Beginning balance at Jan. 31, 2022	$ 648,245	$ (301)		$ 27	1,423,151	2,096	(777,029)	$ (301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)	4,893,120
Net unrealized gain on available-for-sale securities, net of taxes	$ (1,235)
Net loss	(124,125)
Ending balance (in shares) at Oct. 31, 2022				269,372,942
Ending balance at Oct. 31, 2022	594,167			$ 27	1,494,652	943	(901,455)
Beginning balance (in shares) at Apr. 30, 2022				265,931,102
Beginning balance at Apr. 30, 2022	630,706			$ 27	1,450,098	2,271	(821,690)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				605,690
Issuance of Class A common stock from the exercise of common stock options	1,455				1,455
Issuance of Class A common stock upon vesting of restricted stock units (in shares)				1,061,915
Vesting of early exercised stock options (in shares)				91,911
Vesting of early exercised stock options	896				896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)				(381,149)
Class A common stock withheld to satisfy employee tax withholding obligations	(1,753)				(1,753)
Stock-based compensation	21,033				21,033
Net unrealized gain on available-for-sale securities, net of taxes	303					303
Other	390				390
Change in translation	142					142
Net loss	(39,529)						(39,529)
Ending balance (in shares) at Jul. 31, 2022				267,309,469
Ending balance at Jul. 31, 2022	613,643			$ 27	1,472,119	2,716	(861,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)				1,452,777
Issuance of Class A common stock from the exercise of common stock options	4,491				4,491
Issuance of Class A common stock upon vesting of restricted stock units (in shares)				817,320
Vesting of early exercised stock options (in shares)				91,911
Vesting of early exercised stock options	896				896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)				(298,535)
Class A common stock withheld to satisfy employee tax withholding obligations	(2,164)				(2,164)
Stock-based compensation	19,810				19,810
Net unrealized gain on available-for-sale securities, net of taxes	(1,538)					(1,538)
Other	(500)				(500)
Change in translation	(235)					(235)
Net loss	(40,236)						(40,236)
Ending balance (in shares) at Oct. 31, 2022				269,372,942
Ending balance at Oct. 31, 2022	$ 594,167			$ 27	$ 1,494,652	$ 943	$ (901,455)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Operating activities
Net loss	$ (124,125)	$ (91,159)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	33,997	33,865
Stock-based compensation, net of capitalized cost of $1,261 and $514, respectively	59,841	12,619
Change in fair value of convertible notes and warrant liabilities	(5,369)	11,429
Deferred income taxes	39	406
Amortization of debt discount and issuance costs	0	2,328
Other	516	140
Changes in operating assets and liabilities
Accounts receivable	15,237	32,336
Prepaid expenses and other assets	(9,472)	(12,860)
Accounts payable, accrued and other liabilities	(8,649)	2,061
Deferred revenue	(19,382)	(17,401)
Deferred hosting costs	(1,751)	6,759
Deferred rent	0	(1,539)
Net cash used in operating activities	(59,118)	(21,016)
Investing activities
Purchases of property and equipment	(9,008)	(6,051)
Capitalized internal-use software	(1,737)	(2,678)
Maturities of available-for-sale securities	13,000	0
Purchases of available-for-sale securities	(239,321)	0
Other	(412)	(454)
Net cash used in investing activities	(237,478)	(9,183)
Financing activities
Proceeds from the exercise of common stock options	10,909	6,866
Class A common stock withheld to satisfy employee tax withholding obligations	(4,328)	0
Proceeds from the early exercise of common stock options	0	17,928
Payment of transaction costs related to the Business Combination	(326)	(5,281)
Other	122	0
Net cash provided by financing activities	6,377	19,513
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,781)	(807)
Net decrease in cash, cash equivalents and restricted cash	(292,000)	(11,493)
Cash, cash equivalents and restricted cash at the beginning of the period	496,814	76,540
Cash, cash equivalents and restricted cash at the end of the period	$ 204,814	$ 65,047

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Cash Flows [Abstract]
Share-based payment arrangement, capitalized costs	$ 372	$ 181	$ 1,261	$ 514

Organization

Organization	9 Months Ended
Organization	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States ( “ U.S.”), Canada, Asia and Europe. The Company has wholly-owned foreign subsidiaries in Canada, Germany, Luxembourg, Singapore and the Netherlands. On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC. See Note 3 for further details of the Business Combination.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2022 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2023 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. Revenue for the three months ended October 31, 2022 includes an out of period adjustment of $2.1 million. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31. Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022 (the “2022 Form 10-K”). The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, whereby dMY IV was treated as the acquired company and Former Planet was treated as the acquirer. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Former Planet issuing stock for the net assets of dMY IV, accompanied by a recapitalization. The net assets of dMY IV were stated at historical cost, with no goodwill or other intangible assets recorded. Former Planet was determined to be the accounting acquirer based on the following predominant factors: • Former Planet’s existing stockholders have the majority voting interest in the combined entity; • Former Planet had the ability to nominate a majority of the initial members of the board of directors of the combined entity; • Former Planet’s senior management became the senior management of the combined entity; and • Former Planet is the larger entity based on historical operating activity and has the larger employee base. The consolidated assets, liabilities and results of operations prior to the Business Combination are those of Former Planet. The shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the exchange ratio of approximately 1.53184 (the “Exchange Ratio”) established in the Business Combination. See Note 3, Business Combination , for additional details. Liquidity Since its inception, the Company has incurred net losses and negative cash flows from operations. The Company expects to incur additional operating losses and negative cash flows from operations as it seeks to expand its business. As of October 31, 2022 and January 31, 2022, the Company had $199.1 million and $490.8 million of cash and cash equivalents, respectively. Additionally, as of October 31, 2022, the Company had short-term investments of $226.2 million which are highly liquid in nature and available for current operations. There were no short-term investments as of January 31, 2022. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, allowances for credit losses, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, the fair value of common stock and other assumptions used to measure stock-based compensation, the fair value of convertible notes and warrants, the fair value of assets acquired, and liabilities assumed from business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements. Due to the COVID-19 Coronavirus pandemic (“COVID-19” or “COVID-19 pandemic”), and current events involving Russia and Ukraine, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur and additional information is obtained. Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. See Note 4, Revenue , for revenue by geographic region. See Note 7, Balance Sheet Components , for long-lived assets by geographic region. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with financial institutions in the U.S. and checking accounts with financial institutions in Canada, Germany, the Netherlands and Singapore that management believes are of high credit quality. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits of cash, cash equivalents or short-term investments. The maximum amount of loss at October 31, 2022 that the Company would incur if parties to cash, cash equivalents and short-term investments failed completely to perform according to the terms of the contracts is $424.5 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of October 31, 2022, two customers accounted for 16% and 12% of accounts receivable, respectively. As of January 31, 2022, four customers accounted for 23%, 14%, 12% and 10% of accounts receivable, respectively. For the three months ended October 31, 2022, one customer accounted for 23% of revenue. For the nine months ended October 31, 2022, two customers accounted for 18% and 10% of revenue, respectively. The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations. The Company contracts with certain third-party service providers to launch satellites. Service providers who provide these services are limited. The inability of launch service providers to contract with the Company could materially impact future operating results. Significant Accounting Policies The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2022 Form 10-K. Updates to those policies are contained herein. Short-term investments The Company’s short-term investments are designated as available-for-sale and carried at fair value, which is based on quoted market prices for such securities, if available, or is estimated on the basis of quoted market prices of financial instruments with similar characteristics. Investments with original maturities greater than 90 days and remaining maturities of less than one year are classified within short-term investments on the Company’s condensed consolidated balance sheets. In addition, investments with maturities beyond one year at the time of purchase that are highly liquid in nature and represent the investment of cash that is available for current operations are classified as short-term investments. Unrealized gains and losses of available-for-sale securities are excluded from earnings and are reported as a component of Other comprehensive income (loss), net of tax, until the security is sold, the security has matured, or the Company determines that the fair value of the security has declined below its adjusted cost basis and the decline is not due to a credit loss. Realized gains and losses on short-term investments are calculated based on the specific identification method and would be reclassified from accumulated other comprehensive income (loss) to other income (expense), net. Short-term investments are evaluated for allowances and impairment quarterly. The Company considers various factors in determining whether an allowance for expected credit losses or an impairment charge should be recognized, such as the credit quality of the issuer, the duration, severity of and the reason for the decline in value, the potential recovery period, and the Company’s intent to sell. No allowances or impairment charges were recognized during the three and nine months ended October 31, 2022 and 2021. Recently Adopted Accounting Pronouncements The following section provides information about accounting pronouncements adopted during the nine months ended October 31, 2022. In February 2016, the FASB issued ASU 2016-02, Leases (“ Topic 842 ”), which supersedes the guidance in former ASC 840, Leases . The new guidance requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use (“ROU”) asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less may be accounted for similar to existing guidance for operating leases under Topic 840. The Company adopted Topic 842 effective February 1, 2022 and applied the new guidance prospectively utilizing the modified retrospective approach. Comparative periods prior to the effective date were not adjusted and continue to be reported in accordance with the previous lease guidance under Topic 840. The Company elected to utilize the package of practical expedients for transition which permitted the Company to not reassess its prior conclusions regarding whether a contract is or contains a lease, lease classification and initial direct costs. Upon adoption, the Company recognized ROU assets and lease liabilities for operating leases of $8.4 million and $11.4 million, respectively. The difference between the ROU assets and lease liabilities resulted from deferred rent liability balances that were reclassified to ROU assets upon adoption. The Company currently has no finance leases. The adoption of Topic 842 did not result in a cumulative effect adjustment to accumulated deficit, did not impact the Company’s previously reported financial results and did not impact the Company’s condensed consolidated statements of operations and comprehensive loss. Additionally, the adoption of Topic 842 had no impact on cash provided by or used in operating, investing or financing activities on the Company’s condensed consolidated statements of cash flows. In June 2016, the FASB issued ASU 2016-13, Financial instruments, Credit Losses (“ Topic 326 ”): Measurement of Credit Losses on Financial Instruments , which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for most financial assets, including trade receivables, available-for-sale debt securities, and other instruments that are not measured at fair value through net income. The Company adopted the new guidance effective February 1, 2022 utilizing the modified retrospective transition method and recorded a $0.3 million adjustment to the beginning accumulated deficit balance to reflect the cumulative effect of the accounting change. The adoption of the new guidance did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. The Company’s accounts receivable include amounts billed and billable to customers as of the end of the applicable period and do not bear interest. Accounts receivable are stated net of an estimated allowance for credit losses. Effective February 1, 2022, the allowance is assessed by applying a historical loss-rate methodology in accordance with Topic 326, adjusted as necessary based on the Company's review of accounts receivable, specifically reviewing factors including the age of the balances, customer payment history, creditworthiness, and other factors. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. If it is deemed certain that an amount is uncollectible, the amount is written-off. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, a new accounting standard update to simplify the measurement of goodwill by eliminating the Step 2 impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The Company adopted ASU 2017-04 effective February 1, 2022 which did not impact the Company’s condensed consolidated financial statements and related disclosures. In December 2019, the FASB issued ASU 2019-12, Income Taxes ( “Topic 740” ): Simplifying the Accounting for Income Taxes,

Business Combination

Business Combination	9 Months Ended
Business Combination	Oct. 31, 2022
Reverse Recapitalization [Abstract]
Business Combination	Business Combination As discussed in Note 1, the Company completed the Business Combination on December 7, 2021, pursuant to the Merger Agreement. Upon the consummation of the Business Combination, the following events contemplated by the Merger Agreement occurred, based on Former Planet’s capitalization as of December 7, 2021: • all Former Planet convertible preferred stock converted into shares of Former Planet Class A common stock and all Former Planet convertible preferred stock warrants became warrants for Former Planet Class A common stock (see Note 10); • the Venture Tranche B loans and the 2020 Convertible Notes converted into shares of Former Planet Class A common stock; • each share of Former Planet capital stock (other than Former Planet Class B common stock) was converted into the right to receive shares of Planet’s Class A common stock after giving effect to the Exchange Ratio of approximately 1.53184 as calculated in accordance with the Merger Agreement; • each share of Former Planet Class B common stock was converted into the right to receive shares of Planet’s Class B common stock after giving effect to the Exchange Ratio of approximately 1.53184 as calculated in accordance with the Merger Agreement; • all granted and outstanding unexercised Former Planet stock options were converted into Planet stock options exercisable for shares of Planet’s Class A common stock with the same terms and vesting conditions except for the number of shares exercisable and the exercise price, each of which was adjusted by the Exchange Ratio; • all granted and outstanding unvested Former Planet restricted stock units were converted into Planet restricted units for shares of Planet’s Class A common stock with the same terms and vesting conditions except for the number of shares, which was adjusted by the Exchange Ratio; and • Former Planet Class A common stock warrants that remained outstanding subsequent to the closing of the Business Combination were converted into warrants for Planet’s Class A common stock with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted by the Exchange Ratio Pursuant to the Merger Agreement, Former Planet equity holders, including Former Planet equity award holders, will have the right to receive up to an additional 27,000,000 shares in earnout consideration (the “Earn-out Shares”), of which up to 24,600,000 shares may be issued as shares of Class A common stock and up to 2,400,000 may be issued to William Marshall and Robert Schingler, Jr. (the “Planet Founders”) as shares of Class B common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Earn-out Shares that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration. Approximately 5,540,990 shares of the Earn-out Shares were allocated to Former Planet equity award holders, which are accounted for as stock-based compensation pursuant to ASC 718, Compensation—Stock Compensation because service must be provided through each market condition vesting requirement described above. The remaining Earn-out Shares are accounted for as equity classified equity instruments, were included as merger consideration as part of the Business Combination, and recorded in additional paid-in capital. Additionally, the shares of dMY IV Class B common stock automatically converted to 8,625,000 shares of the Company’s Class A common stock (the “dMY Sponsor Shares”), of which, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 862,500 shares are subject to vesting under conditions consistent with the Earn-out Shares discussed above (the “dMY Sponsor Earn-out Shares”). The dMY Sponsor Earn-out Shares are accounted for as equity classified equity instruments, were included as merger consideration as part of the Business Combination, and recorded in additional paid-in capital. On July 7, 2021, in connection with the execution of the Merger Agreement, and on September 13, 2021, following receipt of interest expressed by additional subscribers after the announcement of the Business Combination, dMY IV entered into subscription agreements (collectively, the “Subscription Agreements”) with certain parties subscribing for shares of dMY IV’s Class A common stock (such parties, the “Subscribers”), pursuant to which the Subscribers agreed to purchase, and dMY IV agreed to sell to the Subscribers, an aggregate of 25,200,000 shares of dMY IV Class A Common Stock, for a purchase price of $10.00 per share. Immediately prior to the closing of the Business Combination, the Company issued and sold 25,200,000 shares of its Class A common stock to the Subscribers for aggregate gross proceeds to the Company of $252.0 million (the “PIPE Investment”). In connection with the Business Combination transactions, the outstanding principal, accrued interest and repayment fees of $67.1 million of the credit agreement with SVB and Hercules was repaid (see Note 10). The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, whereby dMY IV was treated as the acquired company and Former Planet was treated as the acquirer. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Former Planet issuing stock for the net assets of dMY IV, accompanied by a recapitalization. The net assets of dMY IV were stated at historical cost, with no goodwill or other intangible assets recorded. The number of shares of the Company’s common stock outstanding immediately following the consummation of the Business Combination and related transactions is as follows: Number of Shares Former Planet stockholders - Class A Common Stock (1) 172,161,152 Former Planet stockholders - Class B Common Stock 21,157,586 dMY IV’s public stockholders - Class A Common Stock (2) 33,810,330 Holders of dMY IV’s sponsor shares - Class A Common Stock (3) 7,762,500 PIPE Investment - Class A Common Stock 25,200,000 Total shares of common stock immediately after Business Combination 260,091,568 (1) Excludes 1,746,296 shares of Class A common stock associated with the early exercise of unvested Former Planet stock options. (2) Upon the closing of the Business Combination, dMY IV’s public stockholders were offered the opportunity to redeem shares of dMY IV Class A common stock then held by them for cash equal to their pro rata share of the aggregate amount on deposit (as of two business days prior to the closing) in the trust account. The table above reflects redemptions of 689,670 shares of Class A common stock that occurred. (3) Excludes 862,500 shares of Class A common associated with the dMY Sponsor Earn-out Shares that are subject to vesting requirements.

Revenue

Revenue	9 Months Ended
Revenue	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Deferred Revenue During the nine months ended October 31, 2022 and 2021, the Company recognized revenue of $50.4 million and $35.3 million, respectively, that had been included in deferred revenue as of January 31, 2022 and 2021, respectively. Remaining Performance Obligations The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices at the anniversary of each year. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $130.8 million as of October 31, 2022, which consists of both deferred revenue of $47.7 million and non-cancelable contracted revenue that will be invoiced in future periods of $83.1 million. The Company expects to recognize approximately 81% of the remaining performance obligation over the next 12 months, approximately 96% of the remaining obligation over the next 24 months, and the remainder thereafter. Remaining performance obligations do not include unexercised contract options, firm orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty. Disaggregation of Revenue The following table disaggregates revenue by major geographic region: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 United States $ 27,191 $ 14,789 $ 71,672 $ 39,293 Norway 3,226 2,100 6,780 10,914 Rest of World 19,287 14,811 59,829 43,856 Total revenue $ 49,704 $ 31,700 $ 138,281 $ 94,063 No single country in the Rest of World accounted for more than 10% of revenue for the three and nine months ended October 31, 2022 and October 31, 2021. Costs to Obtain and Fulfill a Contract Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term. During the three and nine months ended October 31, 2022, the Company deferred $0.2 million and $2.7 million of commission expenditures to be amortized in future periods, respectively. Amortization of commission expenditures was $0.5 million and $1.3 million for the three and nine month periods ended October 31, 2022, respectively. During the three and nine months ended October 31, 2021, the Company deferred $0.1 million and $1.2 million of commission expenditures to be amortized in future periods, respectively. Amortization of commission expenditures was $0.4 million and $1.7 million for the three and nine month periods ended October 31, 2021, respectively. As of October 31, 2022 and January 31, 2022, deferred commissions consisted of the following: (in thousands) October 31, 2022 January 31, 2022 Deferred commission, current $ 1,867 $ 1,375 Deferred commission, non-current 1,964 1,083 Total deferred commission $ 3,831 $ 2,458 The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	9 Months Ended
Fair Value of Financial Assets and Liabilities	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Fair Value of Financial Assets and Liabilities The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of October 31, 2022 and January 31, 2022 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. October 31, 2022 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 64,187 $ — $ — Repurchase securities — 5,000 — Restricted cash: money market funds 5,006 — — Short-term investments: U.S. Treasury securities 55,444 — — Commercial paper — 37,204 — Corporate bonds — 127,553 — U.S. government agency securities — 5,962 — Total assets $ 124,637 $ 175,719 $ — Liabilities Public Warrants $ 7,590 $ — $ — Private Placement Warrants — — 10,265 Total liabilities $ 7,590 $ — $ 10,265 January 31, 2022 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: money market funds $ 470,066 $ — $ — Restricted cash: money market funds 5,875 — — Total assets $ 475,941 $ — $ — Liabilities Public Warrants $ 10,764 $ — $ — Private Placement Warrants — — 12,460 Total liabilities $ 10,764 $ — $ 12,460 The fair value of cash held in banks and accrued liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the table above. The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three and nine months ended October 31, 2022 and 2021. The Public Warrants are classified within Level 1 as they are publicly traded and have an observable market price in an active market. The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data. Level 3 Disclosures The following is a rollforward of Level 3 liabilities measured at fair value: (in thousands) Private Placement Warrants Convertible Notes Preferred Stock Warrant Liability Fair value at end of year, January 31, 2021 $ — $ 101,212 $ 11,359 Change in fair value — 4,691 3,335 Fair value at April 30, 2021 $ — $ 105,903 $ 14,694 Change in fair value — (1,439) (5,330) Fair value at July 31, 2021 $ — $ 104,464 $ 9,364 Change in fair value — 5,489 4,683 Fair value at October 31, 2021 $ — $ 109,953 $ 14,047 Fair value at end of year, January 31, 2022 $ 12,460 $ — $ — Change in fair value (1,068) — — Fair value at April 30, 2022 $ 11,392 $ — $ — Change in fair value (801) — — Fair value at July 31, 2022 $ 10,591 $ — $ — Change in fair value (326) — — Fair value at October 31, 2022 $ 10,265 $ — $ — Private Placement Warrants The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility which was developed based on the historical volatility of a publicly traded set of peer companies. The expected volatility inputs utilized for the fair value measurements of the Private Placement Warrants as of October 31, 2022 and January 31, 2022 were 65.0% and 60.0%, respectively. Convertible Notes In connection with the Business Combination, the convertible notes converted into shares of Class A common stock. The Company measured the fair value of the convertible notes upon conversion based on the closing price of the Company’s Class A common stock on the date of the Business Combination and the number of Class A common stock shares into which the notes converted. As of October 31, 2021, the Company measured its convertible notes at fair value based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy. The fair value of the convertible notes as of October 31, 2021 was estimated using a market approach. The significant unobservable inputs used in the fair value measurement of the Company’s convertible notes are the probability of conversion upon Business Combination and discount for lack of marketability. The following table provides quantitative information associated with the fair value measurement of the convertible notes as of October 31, 2021: Fair Value as of October 31, 2021 Valuation Technique Unobservable Input Input (in thousands) Convertible Notes $109,953 Market Approach Probability of Conversion upon Business Combination 100% Discount for lack of marketability 5% Preferred stock warrant liability In connection with the Business Combination, all preferred stock warrants converted into warrants for Class A common stock. A portion of such Class A common stock warrants were exercised upon the closing of the Business Combination. The Class A common stock warrants that remained outstanding were measured at fair value and classified within stockholders’ equity on the date of the Business Combination. As of October 31, 2021, the Company measured its liabilities for the preferred stock warrants at fair value based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy. The fair value of the preferred stock warrant liabilities as of October 31, 2021 was estimated using a market approach and the Black-Scholes option pricing model. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock warrant liabilities are probability of conversion upon Business Combination, volatility, term and discount for lack of marketability The following table provides quantitative information associated with the fair value measurement of the preferred stock warrant liability as of October 31, 2021: Fair Value as of October 31, 2021 Valuation Technique Unobservable Input Input (in thousands) Preferred Stock Warrant Liability $14,047 Black-Scholes Expected Term 8.4 years Volatility 60% Risk-free interest rate 1.49% Dividend yield 0% Market approach Probability of Conversion upon Business Combination 100% Discount for lack of 5% Other

Leases

Leases	9 Months Ended
Leases	Oct. 31, 2022
Leases [Abstract]
Leases	Leases The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of October 31, 2022, the Company has no finance leases. The Company’s lease agreements do not contain residual value guarantees or material restrictive covenants. Certain of the Company’s leases include escalation clauses, options to renew and options for early termination. The Company utilizes the base, non-cancelable period as the lease term when initially recognizing right-of-use assets and lease liabilities, unless it is reasonably certain that a renewal or termination option will be exercised. Leases with an initial term of 12 months or less are not recorded on the Company’s condensed consolidated balance sheet and expense for these leases are recognized on a straight-line basis over the lease term. The Company does not separate lease and non-lease components for its operating leases. Operating lease costs were $1.8 million and $4.7 million for the three and nine months ended October 31, 2022, respectively. Variable lease expenses, short-term lease expenses and sublease income were immaterial for the three and nine months ended October 31, 2022. Operating cash flows from operating leases were $1.9 million and $5.9 million for the three and nine months ended October 31, 2022, respectively. Right of use assets obtained in exchange for operating lease liabilities were $11.7 million for the three and nine month periods ended October 31, 2022. Maturities of operating lease liabilities as of October 31, 2022 were as follows: (in thousands) Remainder of Fiscal Year 2023 $ 1,834 2024 4,069 2025 5,147 2026 5,063 2027 3,905 Thereafter 31 Total lease payments $ 20,049 Less: Imputed interest (2,487) Total lease liabilities $ 17,562 Weighted average remaining lease term (years) 3.8 Weighted average discount rate 6.8 % As the rate implicit in the lease is generally not readily determinable for the Company’s operating leases, the discount rates used to determine the present value of the Company’s lease liabilities are based on the Company’s incremental borrowing rate at the lease commencement date and commensurate with the remaining lease term. The incremental borrowing rate for a lease is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments in a similar economic environment. To determine the incremental borrowing rate, the Company references market yield curves which are risk-adjusted to approximate a collateralized rate. In accordance with ASC Topic 840, rent expense for the three and nine months ended October 31, 2021 was $0.8 million and $2.3 million, respectively, net of sublease income. Sublease income was immaterial for the three and nine months ended October 31, 2021.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
Balance Sheet Components	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Cash and Cash Equivalents and Restricted cash Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase. The Company had restricted cash balances of $5.7 million and $6.1 million as of October 31, 2022 and January 31, 2022, respectively. The restricted cash balances as of October 31, 2022 primarily consisted of $4.1 million of collateral money market accounts for the Company’s headquarters and other domestic office operating leases and $1.3 million of performance guarantees required for the Company’s foreign sales activities. The restricted cash balances as January 31, 2022 primarily consisted of $4.2 million of collateral money market accounts for the Company’s headquarters and other domestic office operating leases and $1.6 million of performance guarantees required for the Company’s foreign sales activities. A reconciliation of the Company’s cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of October 31, 2022 and January 31, 2022 is as follows: (in thousands) October 31, 2022 January 31, 2022 Cash and cash equivalents $ 199,124 $ 490,762 Restricted cash, current 527 309 Restricted cash, non-current 5,163 5,743 Total cash, cash equivalents and restricted cash $ 204,814 $ 496,814 The current restricted cash balances as of October 31, 2022 and January 31, 2022 are included in prepaid expenses and other current assets. Short-term Investments Short-term investments consisted of the following as of October 31, 2022: Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 55,703 $ — $ (259) $ 55,444 Commercial paper 37,124 80 — 37,204 Corporate bonds 128,536 — (983) 127,553 U.S. government agency securities 6,035 — (73) 5,962 Total short-term investments $ 227,398 $ 80 $ (1,315) $ 226,163 The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2022: October 31, 2022 (in thousands) Amortized Cost Fair Value Due in 1 year or less $ 139,754 $ 139,332 Due in 1-2 years 87,644 86,831 $ 227,398 $ 226,163 There were no short-term investments as of January 31, 2022. Property and Equipment, Net Property and equipment, net consists of the following: (in thousands) October 31, 2022 January 31, 2022 Satellites* $ 314,410 $ 310,861 Leasehold improvements 15,363 15,448 Ground stations and ground station equipment 15,024 12,685 Office furniture, equipment and fixtures 5,546 5,335 Computer equipment and purchased software 8,365 8,197 Total property and equipment, gross 358,708 352,526 Less: Accumulated depreciation (243,323) (219,246) Total property and equipment, net $ 115,385 $ 133,280 * Satellites include $13.6 million and $13.7 million of satellites in process and not placed into service as of October 31, 2022 and January 31, 2022, respectively. There was no interest expense associated with manufactured satellites for the three and nine months ended October 31, 2022. Interest expense associated with manufactured satellites was not material for the three and nine months ended October 31, 2021. The Company’s long-lived assets by geographic region are as follows: (in thousands) October 31, 2022 January 31, 2022 United States $ 110,834 $ 130,230 Rest of World 4,551 3,050 Total property and equipment, net $ 115,385 $ 133,280 The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of October 31, 2022 and January 31, 2022. Total depreciation expense for the three and nine months ended October 31, 2022 was $9.4 million and $30.0 million, respectively, of which $9.0 million and $27.2 million, respectively, was depreciation expense specific to satellites. Total depreciation expense for the three and nine months ended October 31, 2021 was $9.6 million and $28.1 million, respectively, of which $8.4 million and $24.5 million, respectively, was depreciation expense specific to satellites. Capitalized Internal-Use Software Development Costs Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) October 31, 2022 January 31, 2022 Capitalized internal-use software $ 38,795 $ 36,453 Less: Accumulated amortization (27,614) (25,685) Capitalized internal-use software, net $ 11,181 $ 10,768 There was no interest expense associated with capitalized internal-use software costs for the three and nine months ended October 31, 2022. Interest expense associated with capitalized internal-use software costs was not material for the three and nine months ended October 31, 2021. Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2022 was $0.7 million and $1.9 million, respectively. Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2021 was $1.3 million and $4.5 million, respectively. Goodwill and Intangible Assets Goodwill and Intangible assets consist of the following: October 31, 2022 January 31, 2022 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 16,557 $ (8,548) $ (8) $ 8,001 $ 16,557 $ (7,583) $ (9) $ 8,965 Image library 12,194 (10,851) 262 1,605 12,028 (10,610) 104 1,522 Customer relationships 3,951 (2,619) 7 1,339 3,951 (2,161) 8 1,798 Trade names and other 4,551 (3,117) 40 1,474 4,551 (2,678) 39 1,912 Total intangible assets $ 37,253 $ (25,135) $ 301 $ 12,419 $ 37,087 $ (23,032) $ 142 $ 14,197 Goodwill $ 101,413 $ — $ 1,806 $ 103,219 $ 101,413 $ — $ 1,806 $ 103,219 Amortization expense for the three and nine months ended October 31, 2022 was $0.7 million and $2.1 million, respectively. Amortization expense for the three and nine months ended October 31, 2021 was $0.5 million and $1.3 million, respectively. Estimated future amortization expense of intangible assets at October 31, 2022, is as follows: (in thousands) Remainder of Fiscal Year 2023 $ 775 2024 3,056 2025 2,136 2026 1,214 2027 1,108 Thereafter 4,130 $ 12,419 Accrued and Other Current Liabilities Accrued liabilities and other current liabilities consist of the following: (in thousands) October 31, 2022 January 31, 2022 Deferred R&D service liability (see Note 8) $ 22,673 $ 21,878 Payroll and related expenses 5,254 6,007 Deferred hosting costs 4,512 3,967 Deferred rent — 2,193 Withholding taxes and other taxes payable 1,803 3,731 Other accruals 8,387 11,047 Total accrued and other current liabilities $ 42,629 $ 48,823

Research and Development Arrang

Research and Development Arrangements	9 Months Ended
Research and Development Arrangements	Oct. 31, 2022
Research and Development [Abstract]
Research and Development Arrangements	Research and Development Arrangements Research and Development Services Agreement In December 2020, the Company entered into a development services agreement whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “ R&D Services Agreement ”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for a fee of $45.8 million to be paid to the Company as specified milestones are achieved over a three year period. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development . As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method. During the three and nine months ended October 31, 2022, the Company recognized $4.1 million and $10.7 million of fees and incurred $4.1 million and $10.7 million of research and development expenses, respectively, in connection with the R&D Services Agreement. During the three and nine months ended October 31, 2021, the Company recognized $1.4 million and $2.7 million of fees and incurred $1.5 million and $2.8 million of research and development expenses, respectively. As of October 31, 2022 and January 31, 2022 , the Company had received a total of $36.3 million and $26.7 million, respectively, under the R&D Services Agreement. NASA Communication Services Project In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors –Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
Commitment and Contingencies	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Launch Services The Company has purchase commitments for future satellite launch services to be performed by third- parties subsequent to October 31, 2022. Future purchase commitments under noncancelable launch service contracts as of October 31, 2022 are as follows: (in thousands) Remainder of Fiscal Year 2023 $ 45 2024 1,025 Thereafter — Total purchase commitments $ 1,070 Other The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 12). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of October 31, 2022 is as follows: (in thousands) Remainder of Fiscal Year 2023 $ 4,453 2024 28,050 2025 30,120 2026 31,190 2027 32,725 Thereafter 33,427 Total purchase commitments $ 159,965 Contingencies The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims, individually or in the aggregate, that are expected to have a material adverse impact on its condensed consolidated financial statements as of each reporting period. From time to time however, the Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. Indemnification The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. To date, we have not incurred any material costs, and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.

Debt, Convertible Notes, and Wa

Debt, Convertible Notes, and Warrants	9 Months Ended
Debt, Convertible Notes, and Warrants	Oct. 31, 2022
Debt Disclosure [Abstract]
Debt, Convertible Notes, and Warrants	Debt, Convertible Notes, and Warrants The terms of the Company's debt, convertible notes and warrants are described in Note 9, Debt, Convertible Notes, and Warrants , in the Notes to the Consolidated Financial Statements in the 2022 Form 10-K. Venture Loan Amendment On June 21, 2019, the Company amended the 2017 loan agreements with Venture Lending & Leasing, Inc. (“ Venture ”), an affiliate of Western Technology Investment (the “ Amendment ”). Following the Amendment, Tranche B, consisting of two separate subordinated contract liability instruments of $4.3 million each, remained outstanding for which the Company elected to apply the fair value option. The Tranche B loans were classified as a current liability and were measured at a fair value of $10.9 million at issuance. Changes in fair value were subsequently recognized in the condensed consolidated statements of operations and comprehensive loss. In July 2021, the Company amended certain terms of its Venture Tranche B loans and certain terms of the warrants issued to Venture. In connection with the Business Combination (see Note 3), the Venture Tranche B loans converted into 754,378 shares of the Company’s Class A common stock, and there were no loan amounts outstanding as of October 31, 2022 or January 31, 2022 . SVB & Hercules Loan On June 21, 2019, the Company entered into a Credit Agreement with Silicon Valley Bank (“SVB”) and Hercules Capital, Inc. (“Hercules”) for a $50 million secured loan with an interest rate of 11.0% per annum (the prime rate plus 5.5%, minimum of 11%). The loan was scheduled to mature in June 2022. On June 5, 2020, the Company obtained an additional $15 million secured loan from SVB and Hercules. The loan bore an interest rate of 11.0% per annum and was scheduled to mature on June 21, 2022, or 91 days prior to the maturity date of the 2020 Convertible Notes, described below, if the outstanding 2020 Convertible Notes had not been converted into equity securities. In connection with the loans, the Company issued warrants to the lenders and their affiliates for the purchase of 1,433,956 shares of the Company’s Class A common stock, consisting of 1,049,801 with an exercise price of $0.00001 per share which expire in June 2029, and 384,155 which expire in June 2030. The Company incurred total loan fees of $0.9 million associated with its entry into the agreements and accrued $1.5 million of final loan fees payable upon maturity of the 2019 Credit Agreement. The proceeds of debt issuances were allocated between debt and the warrants based on their relative fair values. The difference between debt proceeds and the amount of those proceeds allocated to debt gave rise to total debt discounts of $5.8 million. The discount amount due to the warrant of $5.8 million along with the total loan fees of $2.4 million was being amortized as interest expense through maturity using the effective interest method. In connection with the Business Combination (see Note 3), the outstanding principal, accrued interest and repayment fees of $67.1 million relating to the Credit Agreement with SVB and Hercules was repaid. Therefore, there were no loan amounts outstanding as of October 31, 2022 or January 31, 2022. 2020 Convertible Notes During the fiscal year ended January 31, 2021, the Company entered into a Convertible Note and Warrant Purchase Agreement with certain investors, pursuant to which it issued convertible promissory notes (the “ 2020 Convertible Notes ”). The 2020 Convertible Notes bore interest at a rate of 6.0% per annum, which compounded quarterly and were scheduled to mature on June 22, 2022. The principal amount of 2020 Convertible Notes issued was $71.1 million in aggregate. The Company issued warrants for the purchase of Series D convertible preferred stock, equal to 20% of the original principal amount of the notes, with an exercise price of $9.3844. The warrants expire on the tenth anniversary of the date of issuance. The number of shares of Series D convertible preferred stock issuable under the warrants is 1,515,799 in aggregate. The Company elected to apply the fair value option to the outstanding 2020 Convertible Notes. As such, the 2020 Convertible Notes were recognized at fair value with changes in fair value recognized in the condensed consolidated statements of operations and comprehensive loss. In July 2021, the Company amended certain terms of its 2020 Convertible Notes to provide for, among other things, the automatic conversion of the outstanding principal and accrued interest under the 2020 Convertible Notes into shares of common stock immediately prior to the Business Combination. The amended terms of the 2020 Convertible Notes were not considered substantially different than the original terms of such 2020 Convertible Notes. As such, the 2020 Convertible Notes continued to be recognized at fair value pursuant to the fair value option. In connection with the Business Combination (see Note 3), the 2020 Convertible Notes converted into 9,824,143 shares of the Company’s Class A Common Stock, therefore there were no 2020 Convertible Notes outstanding as of October 31, 2022 or January 31, 2022. In connection with the Business Combination (see Note 3), 450,205 of the Series D convertible preferred stock warrants discussed above converted into warrants for Class A common stock and were exercised on a cashless basis, resulting in the issuance of 27,713 shares of Class A common stock. The remaining 1,065,594 Series D convertible preferred stock warrants that were not exercised converted into warrants for Class A common stock shares and remained outstanding and exercisable as of October 31, 2022 and January 31, 2022. As of October 31, 2022, the outstanding warrants have a weighted average remaining term of 7.4 years. The following table presents the interest expense related to the contractual interest coupon, the amortization of debt issuance costs and the amortization of debt discounts. Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 Contractual interest coupon $ — $ 1,828 $ — $ 5,422 Amortization of debt issuance costs — 229 — 679 Amortization of debt discounts — 555 — 1,649 Total interest expense $ — $ 2,612 $ — $ 7,750

Public and Private Placement Wa

Public and Private Placement Warrants	9 Months Ended
Public and Private Placement Warrants	Oct. 31, 2022
Warrants [Abstract]
Public and Private Placement Warrants	Public and Private Placement Warrants In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share. Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration. As of October 31, 2022 and January 31, 2022, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding.

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Oct. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of October 31, 2022 and January 31, 2022, Google owned greater than 10% of the Company’s common shares with a total investment of 31,942,641 shares of Class A common stock. In March 2020, Google purchased $10.0 million of 2020 Convertible Notes (Note 10). Upon issuance of such 2020 Convertible Notes to Google, the Company also issued warrants to Google for the purchase of 213,119 shares of Series D preferred stock. In connection with the Business Combination, such 2020 Convertible Notes converted to shares of Class A common stock and such Series D preferred stock warrants converted to and were exercised for shares of Class A common stock. In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licenses imagery content to Google. In April 2022, the agreement automatically renewed for a period of one-year. The agreement will terminate in April 2023, unless it is extended for up to one year if the delivery obligations are not met by the company, or it is otherwise renewed at Google’s discretion for an additional year, in each case in accordance with its terms. Additionally, Google may terminate the agreement prior to April 2023 once the Company’s outstanding delivery obligations are completed. As of October 31, 2022 and January 31, 2022, the deferred revenue balance associated with the content license agreement was $2.5 million and $12.2 million, respectively. For the three and nine months ended October 31, 2022, the Company recognized revenue of $3.3 million and $9.7 million, respectively, related to the content license agreement. For the three and nine months ended October 31, 2021, the Company recognized revenue of $1.5 million and $5.6 million, respectively, related to the content license agreement. In addition, the Company purchases hosting and other services from Google, of which $14.4 million and $16.1 million is deferred as of October 31, 2022 and January 31, 2022, respectively. For the three and nine months ended October 31, 2022, the Company recorded hosting expense of $6.0 million and $17.7 million, respectively. For the three and nine months ended October 31, 2021, the Company recorded hosting expense of $5.0 million and $13.7 million, respectively. As of October 31, 2022 and January 31, 2022, the Company’s accounts payable and accrued liabilities balance included $2.5 million and $2.0 million related to hosting and other services provided by Google, respectively.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
Stock-based Compensation	Oct. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to the Business Combination, the Company issued equity awards under the Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan (previously named the Cosmogia Inc. 2011 Stock Incentive Plan) (the “ Legacy Incentive Plans ”). In connection with the Business Combination, the Company adopted the Planet Labs PBC 2021 Incentive Award Plan (the “ Incentive Plan ”). No further awards will be granted under the Legacy Incentive Plans. Directors, employees and consultants are eligible to receive awards under the Incentive Plan; however, ISOs may only be granted to employees. The Company's plans are described in Note 13, Stock-based Compensation , in the Notes to the Consolidated Financial Statements in the 2022 Form 10-K. Stock-Based Compensation The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 Cost of revenue $ 1,317 $ 226 $ 3,992 $ 688 Research and development 8,282 1,901 25,903 4,582 Sales and marketing 3,221 677 10,615 1,959 General and administrative 6,990 2,020 20,592 5,904 Total expense 19,810 4,824 61,102 13,133 Capitalized to internal-use software development costs and property and equipment (372) (181) (1,261) (514) Total stock-based compensation expense $ 19,438 $ 4,643 $ 59,841 $ 12,619 Stock Options A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2022 41,907,551 $ 4.63 6.71 Exercised (4,893,120) $ 2.23 Forfeited (968,342) $ 5.82 Balances at October 31, 2022 36,046,089 $ 4.93 6.33 $ 48,339 Vested and exercisable at October 31, 2022 25,820,674 $ 3.95 5.57 $ 44,025 As of October 31, 2022, total unrecognized compensation cost related to stock options was $35.4 million, which is expected to be recognized over a period of 2.3 years . Restricted Stock Units A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2022 5,439,736 $ 9.42 Vested (2,094,413) $ 7.16 Granted 13,962,454 $ 4.91 Forfeited (933,977) $ 5.73 Balances at October 31, 2022 16,373,800 $ 6.08 During the nine months ended October 31, 2022, the Company granted 13,962,454 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date. Stock-based compensation expense recognized for RSUs during the three and nine months ended October 31, 2022 was $8.5 million and $26.2 million, respectively. As of October 31, 2022, total unrecognized compensation cost related to RSUs was $74.5 million which are expected to be recognized over a period of approximately 3.0 years. RSUs granted in periods prior to the Business Combination were subject to both time-based service and liquidity event vesting requirements. The liquidity event requirement was met upon the closing of the Business Combination on December 7, 2021 and recognition of stock-based compensation commenced on such date. Accordingly, there was no expense recognized for RSUs during the three and nine months ended October 31, 2021. Early Exercises of Stock Options The Legacy Incentive Plans provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of October 31, 2022, the Company had a $13.4 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 1,378,654. Earn-out Shares Pursuant to the Merger Agreement for the Business Combination, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. No Earn-out Shares vested during the three and nine months ended October 31, 2022. As of October 31, 2022, there were 4,469,659 Earn-out Shares outstanding relating to Former Planet equity award holders. During the three and nine months ended October 31, 2022, the Company recognized $6.3 million and $20.6 million of stock-based compensation expense related to the Earn-out Shares, respectively. As of October 31, 2022, total unrecognized compensation cost related to the Earn-out Shares was $11.4 million . These costs are expected to be recognized over a period of approximately 1 year.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded income tax expense of $0.4 million and $0.9 million for the three and nine months ended October 31, 2022. The Company recorded income tax expense of $0.4 million and $0.8 million for the three and nine months ended October 31, 2021. For the three and nine months ended October 31, 2022 and 2021, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three and nine months ended October 31, 2022 and 2021 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences. On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 (“IRA”) into law. There are two major corporate tax provisions included in the Act. The IRA also imposes a 1% excise tax on the repurchase of stock by publicly traded US corporations. The excise tax is effective for stock repurchases after December 31, 2022. The Company does not expect the aforementioned provisions in the IRA to have any impact on the Company’s financial statements. Under the Tax Cuts and Jobs Act of 2017, qualified research expenses incurred after 2021 are no longer immediately deductible and must be amortized over 5 years for tax purposes. The Company does not expect this provision to have a material impact on the Company’s financial statements. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $6.5 million and $5.7 million as of October 31, 2022 and January 31, 2022, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of October 31, 2022 and January 31, 2022 and no such expenses were incurred in the periods presented. The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months. The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
Net Loss Per Share Attributable to Common Stockholders	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Net loss per share calculations for all periods prior to the Business Combination have been retrospectively adjusted for the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse recapitalization. The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (40,236) $ (41,541) $ (124,125) $ (91,159) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 267,947,661 47,137,377 266,104,962 46,360,220 Basic and diluted net loss per share attributable to common stockholders $ (0.15) $ (0.88) $ (0.47) $ (1.97) Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Class A common stock and Class B common stock outstanding would have been anti-dilutive. The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: As of October 31, 2022 2021 Convertible Preferred Stock — 131,252,627 Convertible notes — 8,096,863 Warrants to purchase Series B Convertible Preferred Stock — 761,340 Warrants to purchase Series D Convertible Preferred Stock — 2,261,713 Warrants to purchase Class A common stock 1,065,594 — Common stock options 36,046,089 44,518,179 Restricted Stock Units 16,373,800 5,338,467 Earn-out Shares 25,928,669 — dMY Sponsor Earn-out Shares 862,500 — Public Warrants 6,899,982 — Private Placement Warrants 5,933,333 — Early exercised common stock options, subject to future vesting 1,378,654 1,746,297 Shares issued in connection with acquisition, subject to future vesting 339,619 — 94,828,240 193,975,486

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of presentation and principles of consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2022 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2023 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. Revenue for the three months ended October 31, 2022 includes an out of period adjustment of $2.1 million. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31. Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022 (the “2022 Form 10-K”). The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, whereby dMY IV was treated as the acquired company and Former Planet was treated as the acquirer. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Former Planet issuing stock for the net assets of dMY IV, accompanied by a recapitalization. The net assets of dMY IV were stated at historical cost, with no goodwill or other intangible assets recorded. Former Planet was determined to be the accounting acquirer based on the following predominant factors: • Former Planet’s existing stockholders have the majority voting interest in the combined entity; • Former Planet had the ability to nominate a majority of the initial members of the board of directors of the combined entity; • Former Planet’s senior management became the senior management of the combined entity; and • Former Planet is the larger entity based on historical operating activity and has the larger employee base. The consolidated assets, liabilities and results of operations prior to the Business Combination are those of Former Planet. The shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the exchange ratio of approximately 1.53184 (the “Exchange Ratio”) established in the Business Combination. See Note 3, Business Combination , for additional details.
Use of estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, allowances for credit losses, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, the fair value of common stock and other assumptions used to measure stock-based compensation, the fair value of convertible notes and warrants, the fair value of assets acquired, and liabilities assumed from business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements. Due to the COVID-19 Coronavirus pandemic (“COVID-19” or “COVID-19 pandemic”), and current events involving Russia and Ukraine, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur and additional information is obtained.
Segments	Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Concentration of credit risk and other risks and uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with financial institutions in the U.S. and checking accounts with financial institutions in Canada, Germany, the Netherlands and Singapore that management believes are of high credit quality. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits of cash, cash equivalents or short-term investments. The maximum amount of loss at October 31, 2022 that the Company would incur if parties to cash, cash equivalents and short-term investments failed completely to perform according to the terms of the contracts is $424.5 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of October 31, 2022, two customers accounted for 16% and 12% of accounts receivable, respectively. As of January 31, 2022, four customers accounted for 23%, 14%, 12% and 10% of accounts receivable, respectively. For the three months ended October 31, 2022, one customer accounted for 23% of revenue. For the nine months ended October 31, 2022, two customers accounted for 18% and 10% of revenue, respectively. The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Short-term investments	Short-term investments The Company’s short-term investments are designated as available-for-sale and carried at fair value, which is based on quoted market prices for such securities, if available, or is estimated on the basis of quoted market prices of financial instruments with similar characteristics. Investments with original maturities greater than 90 days and remaining maturities of less than one year are classified within short-term investments on the Company’s condensed consolidated balance sheets. In addition, investments with maturities beyond one year at the time of purchase that are highly liquid in nature and represent the investment of cash that is available for current operations are classified as short-term investments. Unrealized gains and losses of available-for-sale securities are excluded from earnings and are reported as a component of Other comprehensive income (loss), net of tax, until the security is sold, the security has matured, or the Company determines that the fair value of the security has declined below its adjusted cost basis and the decline is not due to a credit loss. Realized gains and losses on short-term investments are calculated based on the specific identification method and would be reclassified from accumulated other comprehensive income (loss) to other income (expense), net.
Recently adopted accounting pronouncements	Recently Adopted Accounting Pronouncements The following section provides information about accounting pronouncements adopted during the nine months ended October 31, 2022. In February 2016, the FASB issued ASU 2016-02, Leases (“ Topic 842 ”), which supersedes the guidance in former ASC 840, Leases . The new guidance requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use (“ROU”) asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less may be accounted for similar to existing guidance for operating leases under Topic 840. The Company adopted Topic 842 effective February 1, 2022 and applied the new guidance prospectively utilizing the modified retrospective approach. Comparative periods prior to the effective date were not adjusted and continue to be reported in accordance with the previous lease guidance under Topic 840. The Company elected to utilize the package of practical expedients for transition which permitted the Company to not reassess its prior conclusions regarding whether a contract is or contains a lease, lease classification and initial direct costs. Upon adoption, the Company recognized ROU assets and lease liabilities for operating leases of $8.4 million and $11.4 million, respectively. The difference between the ROU assets and lease liabilities resulted from deferred rent liability balances that were reclassified to ROU assets upon adoption. The Company currently has no finance leases. The adoption of Topic 842 did not result in a cumulative effect adjustment to accumulated deficit, did not impact the Company’s previously reported financial results and did not impact the Company’s condensed consolidated statements of operations and comprehensive loss. Additionally, the adoption of Topic 842 had no impact on cash provided by or used in operating, investing or financing activities on the Company’s condensed consolidated statements of cash flows. In June 2016, the FASB issued ASU 2016-13, Financial instruments, Credit Losses (“ Topic 326 ”): Measurement of Credit Losses on Financial Instruments , which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for most financial assets, including trade receivables, available-for-sale debt securities, and other instruments that are not measured at fair value through net income. The Company adopted the new guidance effective February 1, 2022 utilizing the modified retrospective transition method and recorded a $0.3 million adjustment to the beginning accumulated deficit balance to reflect the cumulative effect of the accounting change. The adoption of the new guidance did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. The Company’s accounts receivable include amounts billed and billable to customers as of the end of the applicable period and do not bear interest. Accounts receivable are stated net of an estimated allowance for credit losses. Effective February 1, 2022, the allowance is assessed by applying a historical loss-rate methodology in accordance with Topic 326, adjusted as necessary based on the Company's review of accounts receivable, specifically reviewing factors including the age of the balances, customer payment history, creditworthiness, and other factors. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. If it is deemed certain that an amount is uncollectible, the amount is written-off. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, a new accounting standard update to simplify the measurement of goodwill by eliminating the Step 2 impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The Company adopted ASU 2017-04 effective February 1, 2022 which did not impact the Company’s condensed consolidated financial statements and related disclosures. In December 2019, the FASB issued ASU 2019-12, Income Taxes ( “Topic 740” ): Simplifying the Accounting for Income Taxes,

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
Business Combination (Tables)	Oct. 31, 2022
Reverse Recapitalization [Abstract]
Schedule of Business Combination Transactions	The number of shares of the Company’s common stock outstanding immediately following the consummation of the Business Combination and related transactions is as follows: Number of Shares Former Planet stockholders - Class A Common Stock (1) 172,161,152 Former Planet stockholders - Class B Common Stock 21,157,586 dMY IV’s public stockholders - Class A Common Stock (2) 33,810,330 Holders of dMY IV’s sponsor shares - Class A Common Stock (3) 7,762,500 PIPE Investment - Class A Common Stock 25,200,000 Total shares of common stock immediately after Business Combination 260,091,568 (1) Excludes 1,746,296 shares of Class A common stock associated with the early exercise of unvested Former Planet stock options. (2) Upon the closing of the Business Combination, dMY IV’s public stockholders were offered the opportunity to redeem shares of dMY IV Class A common stock then held by them for cash equal to their pro rata share of the aggregate amount on deposit (as of two business days prior to the closing) in the trust account. The table above reflects redemptions of 689,670 shares of Class A common stock that occurred. (3) Excludes 862,500 shares of Class A common associated with the dMY Sponsor Earn-out Shares that are subject to vesting requirements.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table disaggregates revenue by major geographic region: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 United States $ 27,191 $ 14,789 $ 71,672 $ 39,293 Norway 3,226 2,100 6,780 10,914 Rest of World 19,287 14,811 59,829 43,856 Total revenue $ 49,704 $ 31,700 $ 138,281 $ 94,063
Schedule of Deferred Commissions	As of October 31, 2022 and January 31, 2022, deferred commissions consisted of the following: (in thousands) October 31, 2022 January 31, 2022 Deferred commission, current $ 1,867 $ 1,375 Deferred commission, non-current 1,964 1,083 Total deferred commission $ 3,831 $ 2,458

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	9 Months Ended
Fair Value of Financial Assets and Liabilities (Tables)	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. October 31, 2022 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds $ 64,187 $ — $ — Repurchase securities — 5,000 — Restricted cash: money market funds 5,006 — — Short-term investments: U.S. Treasury securities 55,444 — — Commercial paper — 37,204 — Corporate bonds — 127,553 — U.S. government agency securities — 5,962 — Total assets $ 124,637 $ 175,719 $ — Liabilities Public Warrants $ 7,590 $ — $ — Private Placement Warrants — — 10,265 Total liabilities $ 7,590 $ — $ 10,265 January 31, 2022 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: money market funds $ 470,066 $ — $ — Restricted cash: money market funds 5,875 — — Total assets $ 475,941 $ — $ — Liabilities Public Warrants $ 10,764 $ — $ — Private Placement Warrants — — 12,460 Total liabilities $ 10,764 $ — $ 12,460
Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following is a rollforward of Level 3 liabilities measured at fair value: (in thousands) Private Placement Warrants Convertible Notes Preferred Stock Warrant Liability Fair value at end of year, January 31, 2021 $ — $ 101,212 $ 11,359 Change in fair value — 4,691 3,335 Fair value at April 30, 2021 $ — $ 105,903 $ 14,694 Change in fair value — (1,439) (5,330) Fair value at July 31, 2021 $ — $ 104,464 $ 9,364 Change in fair value — 5,489 4,683 Fair value at October 31, 2021 $ — $ 109,953 $ 14,047 Fair value at end of year, January 31, 2022 $ 12,460 $ — $ — Change in fair value (1,068) — — Fair value at April 30, 2022 $ 11,392 $ — $ — Change in fair value (801) — — Fair value at July 31, 2022 $ 10,591 $ — $ — Change in fair value (326) — — Fair value at October 31, 2022 $ 10,265 $ — $ —
Fair Value Measurement Inputs and Valuation Techniques	The following table provides quantitative information associated with the fair value measurement of the convertible notes as of October 31, 2021: Fair Value as of October 31, 2021 Valuation Technique Unobservable Input Input (in thousands) Convertible Notes $109,953 Market Approach Probability of Conversion upon Business Combination 100% Discount for lack of marketability 5% Fair Value as of October 31, 2021 Valuation Technique Unobservable Input Input (in thousands) Preferred Stock Warrant Liability $14,047 Black-Scholes Expected Term 8.4 years Volatility 60% Risk-free interest rate 1.49% Dividend yield 0% Market approach Probability of Conversion upon Business Combination 100% Discount for lack of 5%

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Oct. 31, 2022
Leases [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of October 31, 2022 were as follows: (in thousands) Remainder of Fiscal Year 2023 $ 1,834 2024 4,069 2025 5,147 2026 5,063 2027 3,905 Thereafter 31 Total lease payments $ 20,049 Less: Imputed interest (2,487) Total lease liabilities $ 17,562 Weighted average remaining lease term (years) 3.8 Weighted average discount rate 6.8 %

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
Balance Sheet Components (Tables)	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	A reconciliation of the Company’s cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of October 31, 2022 and January 31, 2022 is as follows: (in thousands) October 31, 2022 January 31, 2022 Cash and cash equivalents $ 199,124 $ 490,762 Restricted cash, current 527 309 Restricted cash, non-current 5,163 5,743 Total cash, cash equivalents and restricted cash $ 204,814 $ 496,814
Schedule of Short-term Investments	Short-term investments consisted of the following as of October 31, 2022: Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 55,703 $ — $ (259) $ 55,444 Commercial paper 37,124 80 — 37,204 Corporate bonds 128,536 — (983) 127,553 U.S. government agency securities 6,035 — (73) 5,962 Total short-term investments $ 227,398 $ 80 $ (1,315) $ 226,163
Schedule of Short-term Investments, Contractual Maturity	The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2022: October 31, 2022 (in thousands) Amortized Cost Fair Value Due in 1 year or less $ 139,754 $ 139,332 Due in 1-2 years 87,644 86,831 $ 227,398 $ 226,163
Schedule of Property and Equipment	Property and equipment, net consists of the following: (in thousands) October 31, 2022 January 31, 2022 Satellites* $ 314,410 $ 310,861 Leasehold improvements 15,363 15,448 Ground stations and ground station equipment 15,024 12,685 Office furniture, equipment and fixtures 5,546 5,335 Computer equipment and purchased software 8,365 8,197 Total property and equipment, gross 358,708 352,526 Less: Accumulated depreciation (243,323) (219,246) Total property and equipment, net $ 115,385 $ 133,280 * Satellites include $13.6 million and $13.7 million of satellites in process and not placed into service as of October 31, 2022 and January 31, 2022, respectively.
Schedule of Long-lived Assets by Geographic Areas	The Company’s long-lived assets by geographic region are as follows: (in thousands) October 31, 2022 January 31, 2022 United States $ 110,834 $ 130,230 Rest of World 4,551 3,050 Total property and equipment, net $ 115,385 $ 133,280
Schedule of Capitalized Computer Software	Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) October 31, 2022 January 31, 2022 Capitalized internal-use software $ 38,795 $ 36,453 Less: Accumulated amortization (27,614) (25,685) Capitalized internal-use software, net $ 11,181 $ 10,768
Schedule of Intangible Assets And Goodwill	Goodwill and Intangible assets consist of the following: October 31, 2022 January 31, 2022 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 16,557 $ (8,548) $ (8) $ 8,001 $ 16,557 $ (7,583) $ (9) $ 8,965 Image library 12,194 (10,851) 262 1,605 12,028 (10,610) 104 1,522 Customer relationships 3,951 (2,619) 7 1,339 3,951 (2,161) 8 1,798 Trade names and other 4,551 (3,117) 40 1,474 4,551 (2,678) 39 1,912 Total intangible assets $ 37,253 $ (25,135) $ 301 $ 12,419 $ 37,087 $ (23,032) $ 142 $ 14,197 Goodwill $ 101,413 $ — $ 1,806 $ 103,219 $ 101,413 $ — $ 1,806 $ 103,219
Schedule of Intangible Assets, Future Amortization Expense	Estimated future amortization expense of intangible assets at October 31, 2022, is as follows: (in thousands) Remainder of Fiscal Year 2023 $ 775 2024 3,056 2025 2,136 2026 1,214 2027 1,108 Thereafter 4,130 $ 12,419
Schedule of Accrued Liabilities and Other Current Liabilities	Accrued liabilities and other current liabilities consist of the following: (in thousands) October 31, 2022 January 31, 2022 Deferred R&D service liability (see Note 8) $ 22,673 $ 21,878 Payroll and related expenses 5,254 6,007 Deferred hosting costs 4,512 3,967 Deferred rent — 2,193 Withholding taxes and other taxes payable 1,803 3,731 Other accruals 8,387 11,047 Total accrued and other current liabilities $ 42,629 $ 48,823

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	9 Months Ended
Commitment and Contingencies (Tables)	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Purchase Commitments	Future purchase commitments under noncancelable launch service contracts as of October 31, 2022 are as follows: (in thousands) Remainder of Fiscal Year 2023 $ 45 2024 1,025 Thereafter — Total purchase commitments $ 1,070
Schedule of Other Commitments	Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of October 31, 2022 is as follows: (in thousands) Remainder of Fiscal Year 2023 $ 4,453 2024 28,050 2025 30,120 2026 31,190 2027 32,725 Thereafter 33,427 Total purchase commitments $ 159,965

Debt, Convertible Notes, and _2

Debt, Convertible Notes, and Warrants (Tables)	9 Months Ended
Debt, Convertible Notes, and Warrants (Tables)	Oct. 31, 2022
Debt Disclosure [Abstract]
Schedule of Debt Expense	The following table presents the interest expense related to the contractual interest coupon, the amortization of debt issuance costs and the amortization of debt discounts. Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 Contractual interest coupon $ — $ 1,828 $ — $ 5,422 Amortization of debt issuance costs — 229 — 679 Amortization of debt discounts — 555 — 1,649 Total interest expense $ — $ 2,612 $ — $ 7,750

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
Stock-based Compensation (Tables)	Oct. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2022 2021 2022 2021 Cost of revenue $ 1,317 $ 226 $ 3,992 $ 688 Research and development 8,282 1,901 25,903 4,582 Sales and marketing 3,221 677 10,615 1,959 General and administrative 6,990 2,020 20,592 5,904 Total expense 19,810 4,824 61,102 13,133 Capitalized to internal-use software development costs and property and equipment (372) (181) (1,261) (514) Total stock-based compensation expense $ 19,438 $ 4,643 $ 59,841 $ 12,619
Summary of Stock Option Activity	A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2022 41,907,551 $ 4.63 6.71 Exercised (4,893,120) $ 2.23 Forfeited (968,342) $ 5.82 Balances at October 31, 2022 36,046,089 $ 4.93 6.33 $ 48,339 Vested and exercisable at October 31, 2022 25,820,674 $ 3.95 5.57 $ 44,025
Summary of Restricted Stock Unit ("RSU") Activity	A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2022 5,439,736 $ 9.42 Vested (2,094,413) $ 7.16 Granted 13,962,454 $ 4.91 Forfeited (933,977) $ 5.73 Balances at October 31, 2022 16,373,800 $ 6.08

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (40,236) $ (41,541) $ (124,125) $ (91,159) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 267,947,661 47,137,377 266,104,962 46,360,220 Basic and diluted net loss per share attributable to common stockholders $ (0.15) $ (0.88) $ (0.47) $ (1.97)
Schedule of Antidilutive Securities	The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: As of October 31, 2022 2021 Convertible Preferred Stock — 131,252,627 Convertible notes — 8,096,863 Warrants to purchase Series B Convertible Preferred Stock — 761,340 Warrants to purchase Series D Convertible Preferred Stock — 2,261,713 Warrants to purchase Class A common stock 1,065,594 — Common stock options 36,046,089 44,518,179 Restricted Stock Units 16,373,800 5,338,467 Earn-out Shares 25,928,669 — dMY Sponsor Earn-out Shares 862,500 — Public Warrants 6,899,982 — Private Placement Warrants 5,933,333 — Early exercised common stock options, subject to future vesting 1,378,654 1,746,297 Shares issued in connection with acquisition, subject to future vesting 339,619 — 94,828,240 193,975,486

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Basis of Presentation and Liquidity (Details)	3 Months Ended
	Oct. 31, 2022 USD ($)	Jan. 31, 2022 USD ($)	Dec. 07, 2021
Accounting Policies [Abstract]
Out of period revenue adjustment	$ 2,100,000
Recapitalization exchange ratio			1.53184
Cash and cash equivalents	199,124,000	$ 490,762,000
Short-term investments	$ 226,163,000	$ 0

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Segments (Details)	9 Months Ended
	Oct. 31, 2022 segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Concentration Risk [Line Items]
Concentration risk, credit risk, maximum exposure		$ 424.5
Customer Concentration Risk \| Accounts Receivable \| Customer 1
Concentration Risk [Line Items]
Concentration risk		16%	23%
Customer Concentration Risk \| Accounts Receivable \| Customer 2
Concentration Risk [Line Items]
Concentration risk		12%	14%
Customer Concentration Risk \| Accounts Receivable \| Customer 3
Concentration Risk [Line Items]
Concentration risk			12%
Customer Concentration Risk \| Accounts Receivable \| Customer 4
Concentration Risk [Line Items]
Concentration risk			10%
Customer Concentration Risk \| Revenue Benchmark \| Customer 1
Concentration Risk [Line Items]
Concentration risk	23%	18%
Customer Concentration Risk \| Revenue Benchmark \| Customer 2
Concentration Risk [Line Items]
Concentration risk		10%

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Feb. 01, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Jan. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets	$ 15,806			$ 8,400	$ 0
Operating lease liabilities	17,562			11,400
Accumulated deficit adjustment	(594,167)	$ (613,643)	$ (630,706)		(648,245)	$ (37,193)	$ (70,278)	$ (83,929)	$ (107,511)
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit adjustment	$ 901,455	$ 861,219	$ 821,690		777,029	$ 731,064	$ 689,523	$ 669,160	$ 639,905
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit adjustment					301
Cumulative Effect, Period of Adoption, Adjustment \| Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit adjustment				$ 300	$ 301

Business Combination - Addition

Business Combination - Additional Information (Details) $ / shares in Units, $ in Millions	Dec. 07, 2021 USD ($) tradingDay $ / shares shares	Jul. 07, 2021 USD ($) $ / shares shares
Reverse Recapitalization [Line Items]
Recapitalization exchange ratio	1.53184
Contingent consideration liability (in shares)	27,000,000
Threshold trading days \| tradingDay	20
Threshold trading days range \| tradingDay	30
Contingent consideration (in shares)	5,540,990
Credit Agreement with SVB and Hercules \| Secured Debt
Reverse Recapitalization [Line Items]
Repayments of debt \| $	$ 67.1
Common Class A
Reverse Recapitalization [Line Items]
Contingent consideration liability (in shares)	24,600,000
Stock converted in transaction (in shares)	8,625,000
Sponsor earnout shares subject to vesting requirements (in shares)	862,500
Number of shares issued in transaction (in shares)		25,200,000
Sale of stock, price per share (in dollars per share) \| $ / shares		$ 10
Sale of stock, consideration received \| $		$ 252
Common Class B
Reverse Recapitalization [Line Items]
Contingent consideration liability (in shares)	2,400,000
Period 1
Reverse Recapitalization [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	$ 15
Period 2
Reverse Recapitalization [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	17
Period 3
Reverse Recapitalization [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	19
Period 4
Reverse Recapitalization [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	$ 21

Business Combination - Schedule

Business Combination - Schedule of Common Stock (Details) - shares	Dec. 07, 2021	Dec. 06, 2021
Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	260,091,568
Common Class A
Reverse Recapitalization [Line Items]
Holders of dMY IV’s sponsor shares - Class A Common Stock (in shares)	7,762,500
PIPE Investment - Class A Common Stock (in shares)	25,200,000
Shares issued upon early exercise of unvested stock options (in shares)		1,746,296
Shares redeemed during the period (in shares)	689,670
Sponsor earnout shares subject to vesting requirements (in shares)	862,500
Former Plan Stockholders \| Common Class A
Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	172,161,152
Former Plan Stockholders \| Common Class B
Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	21,157,586
dMY IV Public Stockholders
Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	33,810,330

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Revenue - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Deferred revenue, revenue recognized			$ 50.4	$ 35.3
Remaining performance obligation, amount	$ 130.8		130.8
Deferred revenue	47.7		47.7
Non-cancelable contract revenue			83.1
Deferred commission expense	0.2	$ 0.1	2.7	1.2
Amortization of deferred commission	$ 0.5	$ 0.4	$ 1.3	$ 1.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	81%		81%
Remaining performance obligation, expected timing of satisfaction	12 months		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	96%		96%
Remaining performance obligation, expected timing of satisfaction	24 months		24 months

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	[1]	$ 49,704	$ 31,700	$ 138,281	$ 94,063
United States
Disaggregation of Revenue [Line Items]
Revenue		27,191	14,789	71,672	39,293
Norway
Disaggregation of Revenue [Line Items]
Revenue		3,226	2,100	6,780	10,914
Rest of World
Disaggregation of Revenue [Line Items]
Revenue		$ 19,287	$ 14,811	$ 59,829	$ 43,856

[1]Balance includes related-party transactions entered into with Google. See Note 12.

Revenue - Schedule of Deferred

Revenue - Schedule of Deferred Commissions (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred commission, current	$ 1,867	$ 1,375
Deferred commission, non-current	1,964	1,083
Total deferred commission	$ 3,831	$ 2,458

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities - Schedule of Fair Value by Balance Sheet Location (Details) - USD ($)	Oct. 31, 2022	Jan. 31, 2022
Assets
Restricted cash: money market funds	$ 5,700,000	$ 6,100,000
Short-term investments	226,163,000	0
Liabilities
Preferred Stock Warrant Liability	17,855,000	23,224,000
U.S. Treasury securities
Assets
Short-term investments	55,444,000
Commercial paper
Assets
Short-term investments	37,204,000
Corporate bonds
Assets
Short-term investments	127,553,000
U.S. government agency securities
Assets
Short-term investments	5,962,000
Fair Value, Recurring \| Level 1
Assets
Restricted cash: money market funds	5,006,000	5,875,000
Total assets	124,637,000	475,941,000
Liabilities
Total liabilities	7,590,000	10,764,000
Fair Value, Recurring \| Level 1 \| Public Warrants
Liabilities
Preferred Stock Warrant Liability	7,590,000	10,764,000
Fair Value, Recurring \| Level 1 \| Private Placement Warrants
Liabilities
Preferred Stock Warrant Liability	0	0
Fair Value, Recurring \| Level 1 \| U.S. Treasury securities
Assets
Short-term investments	55,444,000
Fair Value, Recurring \| Level 1 \| Commercial paper
Assets
Short-term investments	0
Fair Value, Recurring \| Level 1 \| Corporate bonds
Assets
Short-term investments	0
Fair Value, Recurring \| Level 1 \| U.S. government agency securities
Assets
Short-term investments	0
Fair Value, Recurring \| Level 1 \| Money market funds
Assets
Cash equivalents	64,187,000	470,066,000
Fair Value, Recurring \| Level 1 \| Repurchase securities
Assets
Cash equivalents	0
Fair Value, Recurring \| Level 2
Assets
Restricted cash: money market funds	0	0
Total assets	175,719,000	0
Liabilities
Total liabilities	0	0
Fair Value, Recurring \| Level 2 \| Public Warrants
Liabilities
Preferred Stock Warrant Liability	0	0
Fair Value, Recurring \| Level 2 \| Private Placement Warrants
Liabilities
Preferred Stock Warrant Liability	0	0
Fair Value, Recurring \| Level 2 \| U.S. Treasury securities
Assets
Short-term investments	0
Fair Value, Recurring \| Level 2 \| Commercial paper
Assets
Short-term investments	37,204,000
Fair Value, Recurring \| Level 2 \| Corporate bonds
Assets
Short-term investments	127,553,000
Fair Value, Recurring \| Level 2 \| U.S. government agency securities
Assets
Short-term investments	5,962,000
Fair Value, Recurring \| Level 2 \| Money market funds
Assets
Cash equivalents	0	0
Fair Value, Recurring \| Level 2 \| Repurchase securities
Assets
Cash equivalents	5,000,000
Fair Value, Recurring \| Level 3
Assets
Restricted cash: money market funds	0	0
Total assets	0	0
Liabilities
Total liabilities	10,265,000	12,460,000
Fair Value, Recurring \| Level 3 \| Public Warrants
Liabilities
Preferred Stock Warrant Liability	0	0
Fair Value, Recurring \| Level 3 \| Private Placement Warrants
Liabilities
Preferred Stock Warrant Liability	10,265,000	12,460,000
Fair Value, Recurring \| Level 3 \| U.S. Treasury securities
Assets
Short-term investments	0
Fair Value, Recurring \| Level 3 \| Commercial paper
Assets
Short-term investments	0
Fair Value, Recurring \| Level 3 \| Corporate bonds
Assets
Short-term investments	0
Fair Value, Recurring \| Level 3 \| U.S. government agency securities
Assets
Short-term investments	0
Fair Value, Recurring \| Level 3 \| Money market funds
Assets
Cash equivalents	0	$ 0
Fair Value, Recurring \| Level 3 \| Repurchase securities
Assets
Cash equivalents	$ 0

Fair Value of Financial Asset_4

Fair Value of Financial Assets and Liabilities - Schedule of Liabilities with Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021
Convertible Notes
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 0	$ 0	$ 0	$ 104,464	$ 105,903	$ 101,212
Change in fair value	0	0	0	5,489	(1,439)	4,691
Ending balance	0	0	0	109,953	104,464	105,903
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	10,591	11,392	12,460	0	0	0
Change in fair value	(326)	(801)	(1,068)	0	0	0
Ending balance	10,265	10,591	11,392	0	0	0
Preferred Stock Warrant Liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	0	0	9,364	14,694	11,359
Change in fair value	0	0	0	4,683	(5,330)	3,335
Ending balance	$ 0	$ 0	$ 0	$ 14,047	$ 9,364	$ 14,694

Fair Value of Financial Asset_5

Fair Value of Financial Assets and Liabilities - Additional Information (Details)	Oct. 31, 2022	Jan. 31, 2022
Private Placement Warrants \| Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.00650	0.00600

Fair Value of Financial Asset_6

Fair Value of Financial Assets and Liabilities - Measurement Inputs (Details) $ in Thousands	Oct. 31, 2022 USD ($)	Jan. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred Stock Warrant Liability	$ 17,855	$ 23,224
Preferred Stock Warrant Liability \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred Stock Warrant Liability			$ 14,047
Preferred Stock Warrant Liability \| Level 3 \| Expected Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			8.4
Preferred Stock Warrant Liability \| Level 3 \| Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			0.60
Preferred Stock Warrant Liability \| Level 3 \| Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			0.0149
Preferred Stock Warrant Liability \| Level 3 \| Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			0
Preferred Stock Warrant Liability \| Level 3 \| Probability of Conversion upon Business Combination
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			1
Preferred Stock Warrant Liability \| Level 3 \| Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			0.05
Convertible Notes \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible Notes			$ 109,953
Convertible Notes \| Level 3 \| Probability of Conversion upon Business Combination
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt, measurement input			1
Convertible Notes \| Level 3 \| Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt, measurement input			0.05

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Leases [Abstract]
Operating lease, cost	$ 1.8		$ 4.7
Operating lease, payments	1.9		5.9
Right-of-use asset obtained in exchange for operating lease liability	$ 11.7		$ 11.7
Rent expense		$ 0.8		$ 2.3

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Feb. 01, 2022
Leases [Abstract]
Remainder of Fiscal Year 2023	$ 1,834
2024	4,069
2025	5,147
2026	5,063
2027	3,905
Thereafter	31
Total lease payments	20,049
Less: Imputed interest	(2,487)
Total lease liabilities	$ 17,562	$ 11,400
Weighted average remaining lease term (years)	3 years 9 months 18 days
Weighted average discount rate	6.80%

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
Balance Sheet Components - Narrative (Details) - USD ($)	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Restricted cash	$ 5,700,000		$ 5,700,000		$ 6,100,000
Short-term investments	226,163,000		226,163,000		0
Depreciation	9,400,000	$ 9,600,000	30,000,000	$ 28,100,000
Capitalized computer software, amortization	700,000	1,300,000	1,900,000	4,500,000
Amortization of intangible assets	700,000	500,000	2,100,000	1,300,000
Satellites
Property, Plant and Equipment [Line Items]
Depreciation	9,000,000	$ 8,400,000	27,200,000	$ 24,500,000
Money market funds
Property, Plant and Equipment [Line Items]
Restricted cash	4,100,000		4,100,000		4,200,000
Performance Guarantees
Property, Plant and Equipment [Line Items]
Restricted cash	$ 1,300,000		$ 1,300,000		$ 1,600,000

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Cash and Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 199,124	$ 490,762
Restricted cash, current	527	309
Restricted cash, non-current	5,163	5,743
Total cash, cash equivalents and restricted cash	$ 204,814	$ 496,814	$ 65,047	$ 76,540

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Short-term Investments (Details) - USD ($)	Oct. 31, 2022	Jan. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 227,398,000
Gross Unrealized Gains	80,000
Gross Unrealized Losses	(1,315,000)
Fair Value	226,163,000	$ 0
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	55,703,000
Gross Unrealized Gains	0
Gross Unrealized Losses	(259,000)
Fair Value	55,444,000
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	37,124,000
Gross Unrealized Gains	80,000
Gross Unrealized Losses	0
Fair Value	37,204,000
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	128,536,000
Gross Unrealized Gains	0
Gross Unrealized Losses	(983,000)
Fair Value	127,553,000
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	6,035,000
Gross Unrealized Gains	0
Gross Unrealized Losses	(73,000)
Fair Value	$ 5,962,000

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Short-term Investments, Contractual Maturity (Details) - USD ($)	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Amortized Cost, Due in 1 year or less	$ 139,754,000
Amortized Cost, Due in 1-2 years	87,644,000
Amortized Cost	227,398,000
Fair Value, Due in 1 year or less	139,332,000
Fair Value, Due in 1-2 years	86,831,000
Fair Value	$ 226,163,000	$ 0

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 358,708	$ 352,526
Less: Accumulated depreciation	(243,323)	(219,246)
Property and equipment, net	115,385	133,280
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	110,834	130,230
Rest of World
Property, Plant and Equipment [Line Items]
Property and equipment, net	4,551	3,050
Satellites
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	314,410	310,861
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	15,363	15,448
Ground stations and ground station equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	15,024	12,685
Office furniture, equipment and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	5,546	5,335
Computer equipment and purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	8,365	8,197
Satellites, in process and not placed into service
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 13,600	$ 13,700

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Capitalized Software Development (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized internal-use software	$ 38,795	$ 36,453
Less: Accumulated amortization	(27,614)	(25,685)
Capitalized internal-use software, net	$ 11,181	$ 10,768

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Goodwill and Intangibles (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	$ 37,253	$ 37,087
Intangible assets, accumulated amortization	(25,135)	(23,032)
Intangible assets, foreign currency translation	301	142
Intangible assets, net carrying amount	12,419	14,197
Goodwill, gross carrying amount	101,413	101,413
Goodwill, Accumulated Amortization	0	0
Goodwill, foreign currency translation	1,806	1,806
Goodwill, net carrying amount	103,219	103,219
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	16,557	16,557
Intangible assets, accumulated amortization	(8,548)	(7,583)
Intangible assets, foreign currency translation	(8)	(9)
Intangible assets, net carrying amount	8,001	8,965
Image library
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	12,194	12,028
Intangible assets, accumulated amortization	(10,851)	(10,610)
Intangible assets, foreign currency translation	262	104
Intangible assets, net carrying amount	1,605	1,522
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	3,951	3,951
Intangible assets, accumulated amortization	(2,619)	(2,161)
Intangible assets, foreign currency translation	7	8
Intangible assets, net carrying amount	1,339	1,798
Trade names and other
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	4,551	4,551
Intangible assets, accumulated amortization	(3,117)	(2,678)
Intangible assets, foreign currency translation	40	39
Intangible assets, net carrying amount	$ 1,474	$ 1,912

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Intangible Assets, Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Remainder of Fiscal Year 2023	$ 775
2024	3,056
2025	2,136
2026	1,214
2027	1,108
Thereafter	4,130
Intangible assets, net carrying amount	$ 12,419	$ 14,197

Balance Sheet Components - Accr

Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred R&D service liability		$ 22,673	$ 21,878
Payroll and related expenses		5,254	6,007
Deferred hosting costs		4,512	3,967
Deferred rent		0	2,193
Withholding taxes and other taxes payable		1,803	3,731
Other accruals		8,387	11,047
Total accrued and other current liabilities	[1]	$ 42,629	$ 48,823

[1]Balance includes related-party transactions entered into with Google, LLC (“Google”). See Note 12.

Research and Development Arra_2

Research and Development Arrangements (Details) $ in Thousands		1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
		Aug. 31, 2022 USD ($)	Dec. 31, 2020 USD ($) yr	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Jan. 31, 2022 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expense incurred	[1]			$ 27,598	$ 14,959	$ 79,085	$ 39,521
R&D Services Agreement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development arrangement, fee provided			$ 45,800
Research and development arrangement, milestone period \| yr			3
Research and development fee recognized				4,100	1,400	10,700	2,700
Research and development expense incurred				4,100	$ 1,500	10,700	$ 2,800
Proceeds from feeds received						36,300		$ 26,700
NASA Communication Services Project
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development fee recognized				1,200		1,400
Research and development expense incurred				$ 1,300		$ 1,600
Research and development arrangement, funding receivable		$ 40,500

[1]Balance includes related-party transactions entered into with Google. See Note 12.

Commitment and Contingencies -

Commitment and Contingencies - Purchase Commitments (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal Year 2023	$ 45
2024	1,025
Thereafter	0
Total purchase commitments	$ 1,070

Commitment and Contingencies _2

Commitment and Contingencies - Other Commitments (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal Year 2023	$ 4,453
2024	28,050
2025	30,120
2026	31,190
2027	32,725
Thereafter	33,427
Total purchase commitments	$ 159,965

Debt, Convertible Notes, and _3

Debt, Convertible Notes, and Warrants - Venture Loan Amendment (Details) - Secured Term Loan B - Secured Debt	Dec. 07, 2021 shares	Oct. 31, 2022 USD ($)	Jan. 31, 2022 USD ($)	Jun. 21, 2019 USD ($) agreement
Debt Instrument [Line Items]
Subordinated contracts outstanding \| agreement				2
Subordinated contract liability				$ 4,300,000
Debt outstanding		$ 0	$ 0
Shares issued in debt conversion (in shares) \| shares	754,378
Estimate of Fair Value Measurement
Debt Instrument [Line Items]
Debt outstanding				$ 10,900,000

Debt, Convertible Notes, and _4

Debt, Convertible Notes, and Warrants - SVB & Hercules Loan (Details) - Credit Agreement with SVB and Hercules - USD ($)			12 Months Ended
	Dec. 07, 2021	Jun. 21, 2019	Dec. 31, 2019	Oct. 31, 2022	Jan. 31, 2022	Jun. 05, 2020
Common Class A
Debt Instrument [Line Items]
Warrant outstanding (in shares)		1,049,801	1,433,956
Warrant exercise price (in dollars per share)		$ 0.00001
Secured Debt
Debt Instrument [Line Items]
Debt face amount		$ 50,000,000				$ 15,000,000
Debt stated rate		11%				11%
Debt, variable rate floor		11%
Warrant outstanding (in shares)		384,155
Loan fees associated with debt issuance			$ 900,000
Accrued loan fees payable			1,500,000
Debt, unamortized discount			5,800,000
Repayments of debt	$ 67,100,000
Debt outstanding				$ 0	$ 0
Secured Debt \| Warrant
Debt Instrument [Line Items]
Accrued loan fees payable			$ 2,400,000
Secured Debt \| Prime Rate
Debt Instrument [Line Items]
Debt, variable rate spread		5.50%

Debt, Convertible Notes, and _5

Debt, Convertible Notes, and Warrants - 2020 Convertible Note (Details) - 2020 Convertible Notes - USD ($)	Dec. 07, 2021	Oct. 31, 2022	Jan. 31, 2022	Jan. 31, 2021
Debt Instrument [Line Items]
Weighted average remaining term		7 years 4 months 24 days
Series D Convertible Preferred Stock
Debt Instrument [Line Items]
Warrant outstanding (in shares)	450,205	1,065,594	1,065,594
Common Class A
Debt Instrument [Line Items]
Number of shares issued in warrant exercise (in shares)	27,713
Convertible notes
Debt Instrument [Line Items]
Debt stated rate				6%
Debt face amount				$ 71,100,000
Convertible notes \| Series D Convertible Preferred Stock
Debt Instrument [Line Items]
Warrants issued, percent of borrowings principal				20%
Warrant exercise price (in dollars per share)				$ 9.3844
Shares called by warrants (in shares)				1,515,799
Convertible notes \| Common Class A
Debt Instrument [Line Items]
Shares issued in debt conversion (in shares)	9,824,143
Secured Debt
Debt Instrument [Line Items]
Debt outstanding		$ 0	$ 0

Debt, Convertible Notes, and _6

Debt, Convertible Notes, and Warrants - Schedule of Interest Expense and Gain (Loss) on Extinguishment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Debt Disclosure [Abstract]
Contractual interest coupon	$ 0	$ 1,828	$ 0	$ 5,422
Amortization of debt issuance costs	0	229	0	679
Amortization of debt discounts	0	555	0	1,649
Total interest expense	$ 0	$ 2,612	$ 0	$ 7,750

Public and Private Placement _2

Public and Private Placement Warrants (Details)	Dec. 07, 2021 tradingDay $ / shares shares	Mar. 09, 2021 $ / shares shares	Oct. 31, 2022 shares	Jan. 31, 2022 shares	Jul. 07, 2021 $ / shares
Class of Warrant or Right [Line Items]
Threshold trading days \| tradingDay	20
Period 1
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 15
Period 2
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	17
Period 3
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	19
Period 4
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 21
Public Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) \| shares			6,899,982	6,899,982
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) \| shares	2,966,667		5,933,333	5,933,333
Private Placement Warrants, Vesting
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) \| shares			2,966,667	2,966,667
Common Class A
Class of Warrant or Right [Line Items]
Sale of stock, price per share (in dollars per share)					$ 10
Common Class A \| Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)		$ 11.50
dMY IV, LLC
Class of Warrant or Right [Line Items]
Equity units issued (in shares) \| shares		34,500,000
dMY IV, LLC \| Redeemable Warrant
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) \| shares		0.2
Warrant exercise price (in dollars per share)		$ 10
dMY IV, LLC \| Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)	$ 11.50
Warrant outstanding (in shares) \| shares	5,933,333
Sale of stock, price per share (in dollars per share)	$ 1.50
dMY IV, LLC \| Common Class A
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) \| shares		1

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2017	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022	Dec. 07, 2021	Jun. 28, 2021	Jan. 31, 2021	Mar. 31, 2020
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)							260,091,568
Deferred revenue		$ 47,700		$ 47,700
Deferred revenue, revenue recognized				50,400	$ 35,300
Deferred hosting costs		4,512		4,512		$ 3,967
Accounts payable and accrued liabilities		2,500		2,500		2,000
Google
Related Party Transaction [Line Items]
Related party transaction, agreement term	5 years
Related party transaction, renewal term	1 year
Purchase commitment								$ 193,000
Google \| Content Licensing
Related Party Transaction [Line Items]
Deferred revenue		2,500		2,500		$ 12,200
Deferred revenue, revenue recognized		3,300	$ 1,500	9,700	5,600
Google \| Hosting and Other Services
Related Party Transaction [Line Items]
Related party costs and expenses		$ 6,000	$ 5,000	$ 17,700	$ 13,700
Convertible notes \| 2020 Convertible Notes
Related Party Transaction [Line Items]
Debt face amount									$ 71,100
Convertible notes \| Google \| 2020 Convertible Notes
Related Party Transaction [Line Items]
Debt face amount										$ 10,000
Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)		248,215,356		248,215,356		241,017,687
Series D Convertible Preferred Stock \| Google
Related Party Transaction [Line Items]
Shares called by warrants (in shares)										213,119
Series D Convertible Preferred Stock \| Convertible notes \| 2020 Convertible Notes
Related Party Transaction [Line Items]
Shares called by warrants (in shares)									1,515,799
Google
Related Party Transaction [Line Items]
Deferred hosting costs		$ 14,400		$ 14,400		$ 16,100
Google \| PlanetLabs
Related Party Transaction [Line Items]
Ownership percentage (greater than)		10%		10%		10%
Google \| PlanetLabs \| Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)		31,942,641		31,942,641		31,942,641

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 19,810	$ 4,824	$ 61,102	$ 13,133
Capitalized to internal-use software development costs and property and equipment	(372)	(181)	(1,261)	(514)
Total stock-based compensation expense	19,438	4,643	59,841	12,619
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	1,317	226	3,992	688
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	8,282	1,901	25,903	4,582
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	3,221	677	10,615	1,959
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 6,990	$ 2,020	$ 20,592	$ 5,904

Stock-based Compensation - Sc_2

Stock-based Compensation - Schedule of Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 $ / shares shares
Number of Options
Outstanding, beginning balance (in shares) \| shares	41,907,551
Exercised (in shares) \| shares	(4,893,120)
Forfeited (in shares) \| shares	(968,342)
Outstanding, ending balance (in shares) \| shares	36,046,089	41,907,551
Vested and exercisable (in shares) \| shares	25,820,674
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 4.63
Exercised (in dollars per share) \| $ / shares	2.23
Forfeited (in dollars per share) \| $ / shares	5.82
Outstanding, beginning balance (in dollars per share) \| $ / shares	4.93	$ 4.63
Vested and exercisable (in dollars per share) \| $ / shares	$ 3.95
Outstanding, weighted average remaining term	6 years 3 months 29 days	6 years 8 months 15 days
Vested and exercisable, weighted average remaining term	5 years 6 months 25 days
Outstanding, aggregate intrinsic value \| $	$ 48,339
Vested and exercisable, aggregate intrinsic value \| $	$ 44,025

Stock-based Compensation - Rest

Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units	9 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of RSUs
Outstanding, beginning balance (in shares) \| shares	5,439,736
Vested (in shares) \| shares	(2,094,413)
Granted (in shares) \| shares	13,962,454
Forfeited (in shares) \| shares	(933,977)
Outstanding, ending balance (in shares) \| shares	16,373,800
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 9.42
Vested (in dollars per share) \| $ / shares	7.16
Granted (in dollars per share) \| $ / shares	4.91
Forfeited (in dollars per share) \| $ / shares	5.73
Outstanding, ending balance (in dollars per share) \| $ / shares	$ 6.08

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details)		3 Months Ended		9 Months Ended
Stock-based Compensation - Additional Information (Details)	Dec. 07, 2021 tradingDay $ / shares	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	Jan. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, options		$ 35,400,000		$ 35,400,000
Share-based compensation expense		19,438,000	$ 4,643,000	59,841,000	$ 12,619,000
Liability from early exercise of stock options		13,446,000		$ 13,446,000		$ 16,135,000
Unvested shares subject to repurchase (in shares) \| shares				1,378,654
Threshold trading days \| tradingDay	20
Threshold trading days range \| tradingDay	30
Period 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	$ 15
Period 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	17
Period 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	19
Period 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) \| $ / shares	$ 21
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				2 years 3 months 18 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				3 years
Granted (in shares) \| shares				13,962,454
Award vesting period				4 years
Share-based compensation expense		8,500,000	$ 0	$ 26,200,000	$ 0
Costs not yet recognized, award other than options		74,500,000		$ 74,500,000
Awards vested (in shares) \| shares				2,094,413
Earn-out Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				1 year
Share-based compensation expense		6,300,000		$ 20,600,000
Costs not yet recognized, award other than options		$ 11,400,000		$ 11,400,000
Awards vested (in shares) \| shares		0		0
Awards outstanding (in shares) \| shares		4,469,659		4,469,659

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended			9 Months Ended
Income Taxes (Details) - USD ($)	Oct. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Income tax expense	$ 439,000		$ 394,000	$ 907,000	$ 822,000
Unrecognized tax benefits	6,500,000			6,500,000		$ 5,700,000
Income tax examination, penalties and interest accrued	$ 0			0		$ 0
Income tax examination, penalties and interest expense		$ 0		$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2022	Oct. 31, 2021
Numerator:
Net loss	$ (40,236)	$ (39,529)	$ (44,360)	$ (41,541)	$ (20,363)	$ (29,255)	$ (124,125)	$ (91,159)
Denominator:
Basic weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares)	267,947,661			47,137,377			266,104,962	46,360,220
Diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares)	267,947,661			47,137,377			266,104,962	46,360,220
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.15)			$ (0.88)			$ (0.47)	$ (1.97)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.15)			$ (0.88)			$ (0.47)	$ (1.97)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	94,828,240	193,975,486
Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	131,252,627
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	8,096,863
Warrants to purchase Series B Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	761,340
Warrants to purchase Series D Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	2,261,713
Warrants to purchase Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,065,594	0
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	36,046,089	44,518,179
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	16,373,800	5,338,467
Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	25,928,669	0
dMY Sponsor Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	862,500	0
Public Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,899,982	0
Private Placement Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	5,933,333	0
Early exercised common stock options, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,378,654	1,746,297
Shares issued in connection with acquisition, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	339,619	0